In this informative eight-page whitepaper by Brian Hampson, VP of Manufacturing Development & Engineering at PCT, and Richard Grant, Global VP of Cell Therapy at Invetech, you’ll learn how to:
Define a Quality Target Product Profile for your cell therapy product early in development
Discover manufacturing equipment and strategies that maximize quality, scalability, and sustainability
Improve cost-effectiveness and commercial viability
Reduce the need for a large up-front investment by integrating and automating patient-specific cell therapy processes
Understand the importance of communication and the characteristics of a successful relationship between a cell therapy developer and a contract development and manufacturing organization (CDMO)
Fill out the form on this page to download the whitepaper.